Clinical outcomes of AcrySof IQ Vivity intraocular lens in patients with age-related macular degeneration after cataract surgery
Recruiting
- Conditions
- Eyes operated by cararact surgery
- Registration Number
- DRKS00030673
- Lead Sponsor
- Promoter's representative of OFTALVIST (Oftalmología Vistahermosa, SL)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
1. Patients undergoing cataract surgery.
2. Early AMD with low or medium risk of progression according to NICE guidelines.
3. Age range of patients between 50 and 80 years.
Exclusion Criteria
1. Intermediate or advanced AMD
2. Other potential ocular alterations
3. Previous ocular surgeries
4. Patients with missing information or missing data will be discarded from the analysis.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate uncorrected monocular distance visual acuity after AcrySof IQ Vivity IOL implantation after cataract surgery in patients with AMD.<br>The study data will be obtained from the clinical history and tests performed on patients treated according to standard clinical practice.
- Secondary Outcome Measures
Name Time Method - Evaluation of refraction, <br>- Evaluation of the patient's visual acuity at intermediate and near distance (with and without distance correction), <br>- Evaluation of the defocus curve, <br>- Satisfaction evaluation.